CalciMedica, Inc. Share Price

CalciMedica, Inc. Share Price

NASDAQ: CALC | Micro Cap
$1.73
+$0.05 (2.98%) Last updated on 31 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CalciMedica, Inc. Stock Performance

Open
$1.75
Prev. Close
$1.68
Circuit Range
N/A
Day Range
$1.73 - $1.75
Year Range
$0.47 - $6.79
Volume
352
Average Traded
$1.74

CalciMedica, Inc. Share Price Today

As of 31 October 2026, CalciMedica, Inc.'s share price is $1.73. The stock opened at $1.75, compared to its previous close of $1.68. During today's trading session, CalciMedica, Inc.'s share price traded between $1.73 and $1.75, with an average price of $1.74. Over the past 52 weeks, the stock has recorded a high of $6.79 and a low of $0.47. In terms of performance, CalciMedica, Inc.'s share price has risen by 203.51% over the last six months and is down 41.55% on a year-on-year basis.

CalciMedica, Inc. Share Price Chart

Line chart of the CalciMedica, Inc. price trend over the selected period. The price rose overall, ranging from 1.73 to 1.77, ending at 1.73.
$1.73$1.75
L
Show Current Price
H

CalciMedica, Inc. Stock Fundamentals & Key Indicators

Market Cap
$25.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.11
Revenue (TTM)
$0.00
Return On Equity (TTM)
-385.27%
Profit Margin
N/A
Debt to Equity
1.67
Quarterly Earnings Growth YoY
1.92%

CalciMedica, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.80-$10.76$4.98-$7.65
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-37.95%146.28%-253.61%

CalciMedica, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$34.36-$13.70-$29.56
Net Profit MarginN/AN/AN/A
Income ChangeN/A60.13%-115.77%

About CalciMedica, Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

CalciMedica, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.64
$1.73
+6.46%
Sep 2026
$2.13
$1.63
+247.22%
Aug 2026
$0.96
$0.47
-52.24%
Jul 2026
$0.98
$0.98
+0.20%
Jun 2026
$0.85
$0.98
+25.38%
May 2026
$0.61
$0.78
+36.84%
Apr 2026
$0.59
$0.57
+5.56%
Mar 2026
$0.49
$0.54
+4.25%
Feb 2026
$0.78
$0.52
-42.12%
Jan 2026
$6.63
$0.90
-86.56%
Dec 2025
$4.34
$6.66
+57.82%
Nov 2025
$3.00
$4.22
+42.57%

CALC Share Price FAQs